![Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis - The Lancet Oncology Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis - The Lancet Oncology](https://www.thelancet.com/cms/attachment/618e2e54-f852-4d2c-b869-631693d2c1b8/gr1_lrg.jpg)
Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis - The Lancet Oncology
![Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11060-017-2619-1/MediaObjects/11060_2017_2619_Fig1_HTML.gif)
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
![Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-020-01042-y/MediaObjects/41375_2020_1042_Fig1_HTML.png)
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
![Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram](https://www.researchgate.net/publication/259989658/figure/fig4/AS:376440932585476@1466761920292/Progression-free-survival-PFS-curve-and-overall-survival-OS-curve-calculated-using.png)
Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram
![Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-020-01042-y/MediaObjects/41375_2020_1042_Fig1_HTML.png)
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
![Frontiers | Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors Frontiers | Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors](https://www.frontiersin.org/files/Articles/566357/fonc-10-01349-HTML/image_m/fonc-10-01349-g002.jpg)
Frontiers | Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors
![Kaplan-Meier survival curves of progression-free survival and overall... | Download Scientific Diagram Kaplan-Meier survival curves of progression-free survival and overall... | Download Scientific Diagram](https://www.researchgate.net/publication/328503700/figure/fig1/AS:685619827187714@1540475913713/Kaplan-Meier-survival-curves-of-progression-free-survival-and-overall-survival-according.png)
Kaplan-Meier survival curves of progression-free survival and overall... | Download Scientific Diagram
![On Biostatistics and Clinical Trials: Understanding the endpoints in oncology: overall survival, progression free survival, hazard ratio, censored value On Biostatistics and Clinical Trials: Understanding the endpoints in oncology: overall survival, progression free survival, hazard ratio, censored value](http://1.bp.blogspot.com/-kUQ4plu5Z10/VetKmGP3SNI/AAAAAAAAAk0/EcsbkS6qlFQ/w1200-h630-p-k-no-nu/image002.gif)
On Biostatistics and Clinical Trials: Understanding the endpoints in oncology: overall survival, progression free survival, hazard ratio, censored value
![Frontiers | Predicting Progression-Free Survival Using MRI-Based Radiomics for Patients With Nonmetastatic Nasopharyngeal Carcinoma Frontiers | Predicting Progression-Free Survival Using MRI-Based Radiomics for Patients With Nonmetastatic Nasopharyngeal Carcinoma](https://www.frontiersin.org/files/Articles/524388/fonc-10-00618-HTML/image_m/fonc-10-00618-g003.jpg)
Frontiers | Predicting Progression-Free Survival Using MRI-Based Radiomics for Patients With Nonmetastatic Nasopharyngeal Carcinoma
![Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-28410-9/MediaObjects/41467_2022_28410_Fig1_HTML.png)
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
![Progression-free survival by IRC Shown is the Kaplan-Meier curve for... | Download Scientific Diagram Progression-free survival by IRC Shown is the Kaplan-Meier curve for... | Download Scientific Diagram](https://www.researchgate.net/publication/287497086/figure/fig2/AS:614128121024512@1523430962501/Progression-free-survival-by-IRC-Shown-is-the-Kaplan-Meier-curve-for-estimated-PFS-among.png)
Progression-free survival by IRC Shown is the Kaplan-Meier curve for... | Download Scientific Diagram
![Frontiers | Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis Frontiers | Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis](https://www.frontiersin.org/files/Articles/810580/fonc-12-810580-HTML-r1/image_m/fonc-12-810580-g001.jpg)
Frontiers | Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
![Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-018-0155-7/MediaObjects/41408_2018_155_Fig1_HTML.png)